| Trial ID: | L0015 |
| Source ID: | NCT01963845
|
| Associated Drug: |
Sitagliptin
|
| Title: |
Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT01963845/results
|
| Conditions: |
Non-alcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Sitagliptin|Drug: Placebo
|
| Outcome Measures: |
Percentage Change in Liver Fat Relative to Baseline Assessed by MRI-PDFF|AST, Aspartate Aminotransferase|ALT, Alanine Aminotransferase|LDL, Low-density Lipoprotein|HOMA-IR, Homeostatic Model Assessment of Insulin Resistance
|
| Sponsor/Collaborators: |
University of California, San Diego
|
| Gender: |
All
|
| Age: |
18 Years to 99 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
January 2014
|
| Completion Date: |
January 2016
|
| Results First Posted: |
October 20, 2016
|
| Last Update Posted: |
October 20, 2016
|
| Locations: |
University of California, San Diego, San Diego, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT01963845
|
